• leader board size
Consumer Research2020-11-05T23:41:25-08:00

Consumer Research

Ascend Wellness Reports Q2 2026 Financial Results

NEW YORK – Ascend Wellness Holdings Inc. reported its Q2 2026 financial results posting net revenue of $126.1 million, a 7.9% sequential increase from $116.9 million in Q1 2026. Retail revenue climbed 11.5% quarter-over-quarter to ...

Trulieve Completes Redomicile to Delaware

TALLAHASSEE – Trulieve Cannabis Corp. completed its redomiciliation from British Columbia, Canada, to the State of Delaware, following a shareholder vote and a Final Order from the British Columbia Supreme Court. The redomicile took effect ...

Fluent Offloads Pennsylvania Dispensaries

NEW YORK – Fluent Corp. has finalized the sale of its three Pennsylvania dispensaries to HIVE Holdings Inc. for $12.5 million in cash, marking a deliberate shift toward debt reduction and operational efficiency. The deal ...

DEA Increases Psychedelics Production Quotas for 2026

WASHINGTON – The Drug Enforcement Administration has approved expanded production limits for key psychedelics, setting the stage for increased scientific inquiry into substances like psilocybin and DMT next year. In a final order published Monday ...

Wyld Acquires Grön

SEATTLE – Wyld, a leading producer of THC-CBD-infused gummies and chocolates, announced its agreement to acquire Grön, a Portland-based maker of sugar-coated pearls and confections, in a move that unites two prominent players in the ...

Week in Review: Cannabis & Psychedelics Industry Highlights

LOS ANGELES – Federal rescheduling under President Trump’s Executive Order sparked widespread state reactions and investor outlooks into early 2026, blending consolidations and expansions with regulatory friction, outright manipulation, and overtures to public opinion. Psychedelics ...

California Allocates $30M in Cannabis Research Grants

SACRAMENTO – California's Department of Cannabis Control has disbursed nearly $30 million to support 22 academic projects examining Cannabis's influence on public health, environmental practices, and the regulated market. The funding, drawn from taxes on ...

Atai Gains Nasdaq Biotechnology Index Spot

NEW YORK – AtaiBeckley N.V., the clinical-stage biopharmaceutical firm born from the November merger of atai Life Sciences and Beckley Psytech, has secured a place in the Nasdaq Biotechnology Index (NBI), a move that underscores ...

Subscribe To Our Newsletter

Go to Top